bt549 breast cancer cell lines (ATCC)
Structured Review
Bt549 Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 3004 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+lines+bt549/BT-549/pm42092157-225-10-32
Average 99 stars, based on 3004 article reviews
Images
Related Articles
Multiple Displacement Amplification:Article Title: Isoliquiritigenin Impedes Breast Cancer Progression through PITX1–PFKP-Mediated Glycolysis Reprogramming Article Snippet: .. All cell lines used in this research, including the normal mammary cell line MCF-10A and the Article Title: C1ql4 regulates breast cancer cell stemness and epithelial-mesenchymal transition through PI3K/AKT/NF-κB signaling pathway. Article Snippet: The antibodies were used as follows: C1ql4, b-actin (1:100 dilution, CST, USA). .. Article Title: C1ql4 regulates breast cancer cell stemness and epithelial-mesenchymal transition through PI3K/AKT/NF-κB signaling pathway Article Snippet: The antibodies were used as follows: C1ql4, β-actin (1:100 dilution, CST, USA). .. Article Title: MEK1 Inhibitor Combined with Irradiation Reduces Migration of Breast Cancer Cells Including miR-221 and ZEB1 EMT Marker Expression. Article Snippet: .. Growth and Maintenance of Cell Lines and 3D-Microtissue Generation The Article Title: Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway. Article Snippet: Triple-negative breast cancer (TNBC) represents the most aggressive subtype of breast cancer that is highly resistant to current therapeutic options.. According to the public databases Oncomine and KM plotter, the CLK4 expression is correlated with poor patient survival in TNBC, especially in mesenchymal-like TNBC (MES-TNBC) that has strong metastatic potential.. Therefore, we investigated the potential involvement of CLK4 in the metastasis and progression of MES-TNBC. Article Title: Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance Article Snippet: .. The following Article Title: MEK1 Inhibitor Combined with Irradiation Reduces Migration of Breast Cancer Cells Including miR-221 and ZEB1 EMT Marker Expression Article Snippet: .. The Article Title: Knockdown of XB130 restrains cancer stem cell-like phenotype through inhibition of Wnt/β-Catenin signaling in breast cancer. Article Snippet: .. A nontumorigenic epithelial cell line MCF‐10a, and Cell Culture:Article Title: C1ql4 regulates breast cancer cell stemness and epithelial-mesenchymal transition through PI3K/AKT/NF-κB signaling pathway. Article Snippet: The antibodies were used as follows: C1ql4, b-actin (1:100 dilution, CST, USA). .. Article Title: C1ql4 regulates breast cancer cell stemness and epithelial-mesenchymal transition through PI3K/AKT/NF-κB signaling pathway Article Snippet: The antibodies were used as follows: C1ql4, β-actin (1:100 dilution, CST, USA). .. Article Title: Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway. Article Snippet: Triple-negative breast cancer (TNBC) represents the most aggressive subtype of breast cancer that is highly resistant to current therapeutic options.. According to the public databases Oncomine and KM plotter, the CLK4 expression is correlated with poor patient survival in TNBC, especially in mesenchymal-like TNBC (MES-TNBC) that has strong metastatic potential.. Therefore, we investigated the potential involvement of CLK4 in the metastasis and progression of MES-TNBC. Modification:Article Title: MEK1 Inhibitor Combined with Irradiation Reduces Migration of Breast Cancer Cells Including miR-221 and ZEB1 EMT Marker Expression. Article Snippet: .. Growth and Maintenance of Cell Lines and 3D-Microtissue Generation The Article Title: MEK1 Inhibitor Combined with Irradiation Reduces Migration of Breast Cancer Cells Including miR-221 and ZEB1 EMT Marker Expression Article Snippet: .. The |

